Supernus Pharmaceuticals Inc. will announce its fourth quarter and full year 2025 financial and business results after market close on February 24, 2026. President and CEO Jack Khattar and Senior Vice President and CFO Tim Dec will host a conference call to present the results on February 24, 2026, at 4:30 p.m. ET. The financial results and live webcast will be available in the Events & Presentations section of the Company's Investor Relations website. A replay of the webcast will be available on the same website for 60 days following the live call. Participants may pre-register for the call at the registration link provided by the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Supernus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001356576-26-000002), on February 12, 2026, and is solely responsible for the information contained therein.